1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: MCC-16025, IRB 108255, NCI Protocol 8461, NCT01042535
|
|
2.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2011LS109, NCT01560923
|
|
3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000576700, MCC-15267, MCC-FL065, 15267, 8045, NCT00567931
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: MCC-16264, MCC-16264, 8784, NCT01191216
|
|
5.
|
Phase: No phase specified Type: Diagnostic, Treatment Status: Approved-not yet active Age: 18 and older Sponsor: NCI Protocol IDs: MCC-16216, MCC-16216, 8701, NCT01302821
|